CNR1 and obesity disorder: Endogenous and exogenous CBs are known to increase appetite and to promote obesity mainly through their interactions with the hypothalamic feeding circuitry [3], and CB1R antagonists were found effective in reducing body weight in experimental animals and in individuals with the common form of diet-related obesity [8], [9], [11].